Novartis’ Cholesterol Drug Inclisiran Closes In On EU Approval

Drug Will Be Known As Leqvio

 
• By Andrew McConaghie
Amsterdam, March 2020. Entrance of the office from the European Medicines Agency (EMA) in Amsterdam
The European Medicine Agency in Amsterdam.

More from Business

More from Scrip